glp-1 market news november 2025 Receptor Agonist Size & Share Report, 2032 GLP-1 Receptor Agonist Market Valued

Lower costs by requiring manufacturers to provide an MFN-based supplemental rebate in addition to the standard Medicaid Drug Rebate Program (MDRP)

The investigators concluded directly: the cardioprotective effects of semaglutide extend beyond its impact on adiposity

Sugary drinks and ultra-processed snacks waste your limited calorie budget on foods that do not support lean mass

Like Nooms color-coding system, the traditional WW points system discourages the consumption of fat, which may be difficult for people choosing to follow a lower-carb, higher-fat diet

The medication mechanism stays the same, but the metabolic environment surrounding it has changed